How to buy Nkarta stock | $62.54

Nkarta, Inc is a biotechnology business based in the US. Nkarta shares (NKTX) are listed on the NASDAQ and all prices are listed in US Dollars.

How to buy shares in Nkarta

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Nkarta. Find the stock by name or ticker symbol: NKTX. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Nkarta reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At last close price of USD$62.54, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Nkarta, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Nkarta. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Nkarta share price

Use our graph to track the performance of NKTX stocks over time.

Nkarta shares at a glance

• Key figures

Information last updated 2020-12-25.

Latest market close	USD$62.54
52-week range	USD$22.46 - USD$79.16
50-day moving average	USD$46.8294
200-day moving average	USD$34.8205
Wall St. target price	USD$73.67
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-0.8775

Buy Nkarta shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy Nkarta stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Nkarta, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Nkarta price performance over time

Historical closes compared with the close of $62.54 from 2020-12-18

1 week (2021-01-07)	12.68%
1 month (2020-12-17)	-7.35%
3 months (2020-10-15)	100.64%
6 months (2020-07-15)	71.11%

1 year (2020-01-13)	N/A
2 years (2019-01-13)	N/A
3 years (2018-01-13)	N/A
5 years (2016-01-13)	N/A

Nkarta financials

Revenue TTM	USD$385
Gross profit TTM	USD$-17,101,570
Return on assets TTM	0%
Return on equity TTM	0%
Profit margin	0%
Book value	N/A
Market capitalisation	USD$2.3 billion

TTM: trailing 12 months

Shorting Nkarta shares

There are currently 1.0 million Nkarta shares held short by investors – that's known as Nkarta's "short interest". This figure is 5.3% up from 967,582 last month.

There are a few different ways that this level of interest in shorting Nkarta shares can be evaluated.

Nkarta's "short interest ratio" (SIR)

Nkarta's "short interest ratio" (SIR) is the quantity of Nkarta shares currently shorted divided by the average quantity of Nkarta shares traded daily (recently around 140552.55172414). Nkarta's SIR currently stands at 7.25. In other words for every 100,000 Nkarta shares traded daily on the market, roughly 7250 shares are currently held short.

However Nkarta's short interest can also be evaluated against the total number of Nkarta shares, or, against the total number of tradable Nkarta shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Nkarta's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Nkarta shares in existence, roughly 30 shares are currently held short) or 0.034% of the tradable shares (for every 100,000 tradable Nkarta shares, roughly 34 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Nkarta.

Find out more about how you can short Nkarta stock.

Nkarta share dividends

We're not expecting Nkarta to pay a dividend over the next 12 months.

Nkarta overview

Nkarta, Inc., a biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the surface of tumor cells. Its co-lead product candidates are NKX101, a pre-clinical product that enhances the power of innate NK biology to detect and kill cancerous cells; and NKX019, a pre-clinical product, which is based on the ability to treat various B cell malignancies by targeting the CD19 antigen found on these types of cancerous cells. The company was founded in 2015 and is headquartered in South San Francisco, California.

Frequently asked questions

• What percentage of Nkarta is owned by insiders or institutions?

  Currently 14.939% of Nkarta shares are held by insiders and 83.899% by institutions.

• When does the fiscal year end for Nkarta?

  Nkarta's fiscal year ends in December.

• Where is Nkarta based?

  Nkarta's address is: 6000 Shoreline Court, South San Francisco, CA, United States, 94080

• What is Nkarta's ISIN number?

  Nkarta's international securities identification number is: US65487U1088